Tariq Ashraf ( National Institute of Cardiovascular Diseases, Karachi )
Asad Pathan ( National Institute of Cardiovascular Diseases, Karachi )
Anis Memon ( National Institute of Cardiovascular Diseases, Karachi )
Ishtiaq Rasool ( National Institute of Cardiovascular Diseases, Karachi )
Asadullah Kundi ( National Institute of Cardiovascular Diseases, Karachi )
June 2008, Volume 58, Issue 6
Case Reports
Abstract
Introduction
In cardiac tamponade initial management is pericardiocentesis followed by surgical intervention if there is repeated accumulation of fluid in the pericardial sac.2
Immediate management of tamponade has its impact on relieving the symptoms, while long term prognosis depends on the root cause of the disease, regardless of any intervening procedure.2-5
Different approaches have been described for managing recurring pericardial effusion. This includes pericardiocentesis, surgically created pericardial window6 and percutaneous balloon pericardiotomy (PBP) which is a less invasive approach as compared to surgery.7
Case Report
Pigtail catheter was kept for three days with continuous drainage of fluid and with daily echocardiography for confirmation of fluid. Catheter was withdrawn on the fourth day and patient was discharged. Patient was again readmitted with cardiac tamponade on fifth day when PBP procedure was decided.
Patient was taken to catheterization laboratory and procedure was performed under local anaesthesia with 1% lidocane and mild sedation with intravenous 25mg pethidine and 5mg diazepam. An 18 G-needle was attached to a 10cc syringe and punctured through subxiphoid region. Fluid was aspirated and a.0.035 guidewire (Medtronic) was placed in the pericardial cavity (Figure 1-A). 6 Fr. Pigtail (Cordis) was placed in the pericardial cavity for drainage. Dye was injected for confirming the position (Figure 1-B) and to help identify the pericardial margin (Figure 1-C). Pigtail was then withdrawn and subxiphoid region dilated with 14 Fr. Dilator (used for atrial septal dilatation) under fluoroscopy to avoid pericardial tear and trauma to the heart. Multitrack balloon catheter 20mm x 5cm (used for mitral valve dilatation) was inflated to ensure creation of an adequate opening of the pericardium by identifying the waist at the site of pericardial margin. (Figure 1-D). After full inflation of balloon (Figure 1-E) and deflation, the dilating catheter was removed and drainage catheter was inserted into pericardial space.[(0)]
Drainage catheter was removed after 24 hours with echo check and then after 48 hours with an x-ray chest which was negative for pleural effusion. Patient was discharged in an asymptomatic condition but was lost to follow up. Absence of follow up is a weakness of our study but it is known that this technique has no immediate or late procedure related complications or recurrence of pericardial effusion.
Discussion
Recurrence of pericardial effusion and tamponade after pericardiocentesis have been reported in 14% to 50% cases.3
Patients who continue to drain more than 100ml/24 hours three days after catheter drainage have been considered for more aggressive therapy. Surgical approach though offers a lower recurrence but is associated with higher morbidity.8 Surgical method should be undertaken in patients with a longer survival.
Our patient who had advanced malignancy and cardiac tamponade was a poor candidate for surgical intervention. Moreover, malnutrition and chemotherapy associated with this disease are more prone to infections and peri-operative complications.2
PBP technique is relatively simple and safe. Mechanism by which PBP works remains unclear. It is assumed that balloon inflation causes localized tearing of parietal pericardial tissue leading to communication of pericardial space with pleural space and possibly with abdominal cavity.9
PBP technique has been studied in multicenter registry.10 No procedure related variables were found to influence either survival or freedom from recurrence. This technique proved beneficial to the patient by relieving the symptoms.
Conclusion
References
2. Mills SA, Julian S, Holliday RH, Vinten-Johnson J, Case LD, Hudspeth AS, et al. Subxiphoid pericardial window for pericardial effusive disease. J Cardiovasc Surg. 1989; 30:768-73.
3. Markiewicz W, Borovik R, Ecker S: Cardiac tamponade in medical patients: Treatment and Prognosis in the echocardiographic era. Am Heart J 1986; 111: 1138-42.
4. Piehler JM, Pluth JR, Schaff HV, Danielson GK, Orszulak TA, Puga FJ. Surgical management of effusive pericardial disease: Influence of extent of pericardial resection on clinical course J. Thorac Cardiovasc Surg 1985: 90: 506-16.
5. Hamid M, Khan MU, Bashour AC. Diagnostic value of Chest X Ray and Echocardiography for cardiac tamponade in post cardiac surgery patients. J. Pak Med Assoc. Mar. 2006: 56: 104-7.
6. Santos GH, Frater RW. The Subxiphoid approach in the treatment of Pericardial effusion . Ann Thorac Surg1977; 23: 467-70.
7. Palacios IF. Tuzcu EM, Ziskind AA, Younger J, Block PC. Percutaneous Balloon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovas Diagn 1991; 22: 244-9.
8. Little AG, Kremser PC, Wade JL, Levett JN, DeMeester TR, Skinner DB. Operation for diagnosis and treatment of pericardial effusions. Surgery 1984; 96; 738-44.
9. Bertrand O, Legrand V, Kulbertus H. Percutaneous balloon pericardiotomy. A Case report and analysis of mechanism of action. Cathet Cardiovasc Diagn 1996; 38: 180-82.
10. Ziskind A, Lemmon C, Rodriguez S. Final report of the percutaneous balloon pericardiotomy registry for the treatment of effusive pericardial disease Circulation 1994: 90: I -121.
Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees:




